Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study

被引:5
作者
Go, Gang Min [1 ]
Oh, Hyun Ju [2 ]
Han, Kyungdo [3 ]
Kim, Yeong Ho [2 ]
Lee, Hyun Ji
Lee, Ji Hyun [2 ]
机构
[1] Catholic Univ Korea, Dept Dermatol, Yeouido St Marys Hosp, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, 222 Banpo Daero, Seoul 06591, South Korea
[3] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Cohort Study; Epidemiological Study; Hormone Replacement Therapy; Psoriasis; Risk Factor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; POSTMENOPAUSAL ESTROGEN; WOMEN; YOUNGER; PRESSURE; RECEPTOR; MARKERS; PROTEIN; EVENTS; BLOOD;
D O I
10.3346/jkms.2023.38.e377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hormone replacement therapy (HRT) is used to relieve menopause symptoms, but has been reported to be associated with coronary heart disease and cancers in women. However, a link between HRT and psoriasis has yet to be established. The aim of this study was to determine the association between HRT and the risk of psoriasis.Methods: We executed a nationwide population-based study. A total of 1,130,741 post-menopause women were enrolled in the national health care insurance database based on the enrollment criteria. The study population was classified into four groups based on the duration of the HRT, and the risk of psoriasis was analyzed.Results: The incidence rates of psoriasis per 1,000 person-years were 3.36 and 4.09 in the no history of HRT and >= 5 years of HRT, respectively. After adjustment for age, smoking, alcohol intake, regular exercise, body mass index, diabetes mellitus, hypertension, and dyslipidemia, the most prolonged duration of the HRT group (>= 5 years) exhibited significantly increased risk of developing psoriasis (hazard ratio, 1.22; 95% confidence interval, 1.16-1.29).Conclusion: We propose that HRT in post-menopausal women is associated with an increased likelihood of psoriasis development.
引用
收藏
页数:10
相关论文
共 45 条
[1]   Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - A beneficial effect on atherogenesis and thrombus formation? [J].
Aune, B ;
Oian, P ;
Omsjo, I ;
Osterud, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (06) :1816-1820
[2]   Comorbidities in psoriasis [J].
Aurangabadkar, Sanjeev J. .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 :S10-S17
[3]   Hormone therapy for preventing cardiovascular disease in post-menopausal women [J].
Boardman, Henry M. P. ;
Hartley, Louise ;
Eisinga, Anne ;
Main, Caroline ;
Roque i Figuls, Marta ;
Bonfill Cosp, Xavier ;
Gabriel Sanchez, Rafael ;
Knight, Beatrice .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03)
[4]   Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women [J].
Brooks-Asplund, EM ;
Tupper, CE ;
Daun, JM ;
Kenney, WL ;
Cannon, JG .
CYTOKINE, 2002, 19 (04) :193-200
[5]   The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial [J].
Buyon, JP ;
Petri, MA ;
Kim, MY ;
Kalunian, KC ;
Grossman, J ;
Hahn, BH ;
Merrill, JT ;
Sammaritano, L ;
Lockshin, M ;
Alarcón, GS ;
Manzi, S ;
Belmont, HM ;
Askanase, AD ;
Sigler, L ;
Dooley, MA ;
Von Feldt, J ;
McCune, WJ ;
Friedman, A ;
Wachs, J ;
Cronin, M ;
Hearth-Holmes, M ;
Tan, M ;
Licciardi, F .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :953-962
[6]   Postmenopausal Hormone Therapy and Risk of Stroke Impact of the Route of Estrogen Administration and Type of Progestogen [J].
Canonico, Marianne ;
Carcaillon, Laure ;
Plu-Bureau, Genevieve ;
Oger, Emmanuel ;
Singh-Manoux, Archana ;
Tubert-Bitter, Pascale ;
Elbaz, Alexis ;
Scarabin, Pierre-Yves .
STROKE, 2016, 47 (07) :1734-1741
[7]   Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? [J].
Cho, Leslie ;
Kaunitz, Andrew M. ;
Faubion, Stephanie S. ;
Hayes, Sharonne N. ;
Lau, Emily S. ;
Pristera, Nicole ;
Scott, Nandita ;
Shifren, Jan L. ;
Shufelt, Chrisandra L. ;
Stuenkel, Cynthia A. ;
Lindley, Kathryn J. .
CIRCULATION, 2023, 147 (07) :597-610
[8]   Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen [J].
Dubey, RK ;
Imthurn, B ;
Barton, M ;
Jackson, EK .
CARDIOVASCULAR RESEARCH, 2005, 66 (02) :295-306
[9]   Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association [J].
El Khoudary, Samar R. ;
Aggarwal, Brooke ;
Beckie, Theresa M. ;
Hodis, Howard N. ;
Johnson, Amber E. ;
Langer, Robert D. ;
Limacher, Marian C. ;
Manson, JoAnn E. ;
Stefanick, Marcia L. ;
Allison, Matthew A. .
CIRCULATION, 2020, 142 (25) :e506-e532
[10]  
Griffiths CEM, 2021, LANCET, V397, P1301, DOI 10.1016/S0140-6736(20)32549-6